Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference

January 11, 2024

https://www.globenewswire.com/news-release/2024/01/11/2807852/0/en/Avenue-Therapeutics-to-Present-at-Sidoti-January-Micro-Cap-Investor-Conference.html

MIAMI, Jan. 11, 2024 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (Nasdaq:ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced that Alexandra MacLean, M.D., Chief Executive Officer, will present a corporate update at the Sidoti January Micro-Cap Investor Conference on Thursday, January 18, 2024 at 10:00 a.m. EST.

Read more at globenewswire.com

Related news for (ATXI)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.